Remove Clinical Trials Remove Data Remove Information Remove Packaging
article thumbnail

InMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial

Puff Puff Post

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov.

article thumbnail

Flora Growth Forms Flora Pharma Division, Launches Global Clinical Trials

Cannabis Law Report

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. The immediate next steps are to submit data for ethics committee review and approval whereupon acceptance, further details will be provided. “A Visit www.floragrowth.ca

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MAPS: Regulatory Publishing Specialist – Remote Position Regulatory Affairs · Any City, Any State, California

Cannabis Law Report

More information about the organization is available at [link]. Reporting to the Regulatory Affairs Manager, the RPS supports functions related to tracking regulatory information and document styling and publishing in eCTD format for regulatory submissions. MAPS PBC is committed to the evolution of psychedelic healing modalities.

article thumbnail

Oxford Cannabinoid Technologies Holdings plc – Pre-Close Trading Update; US OTC QB Market Application & Notice of 2021 Final Results

Cannabis Law Report

At the end of the programme, Evotec will provide the Company with a submission-ready regulatory document which will be used for submissions to regulatory agencies, as well as drug-batch approved and ready for First Time in Human clinical trials. Further information can be found at www.otcmarkets.com/learn/market-101.

article thumbnail

Press Release: Entheon Biomedical Announces EEG Patent Application & Provides Research Update

Cannabis Law Report

EBRX-101 on Track to Submit Regulatory Package for Human DMT Clinical Trial. The Company is pleased to confirm that it is on track to submit its regulatory package to the Dutch ethics committee in early 2022 for its upcoming human trial.

article thumbnail

Radicle Science and Open Book Extracts Announce New Alliance to Advance Consumer Trust and CBD Industry Validation

Cannabis Law Report

Step three: Radicle Science conducts a rigorous randomized controlled trial of the various formulations to reveal differential effects of various ingredients, combinations of ingredients, dosages and delivery methods on various health-related need states. For more information, visit [link] and follow their LinkedIn page.

article thumbnail

Position: Head of Global Regulatory Affairs MAPS PBC California Full-time

Cannabis Law Report

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Develop and maintain the Core Data Sheet and lead global labeling team meetings. Key Responsibilities. Position Requirements.